A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients

British Journal of Cancer ◽

10.1038/s41416-019-0391-z ◽

2019 ◽

Vol 120 (5) ◽

pp. 475-480 ◽

Author(s):

Yasuhiro Fujiwara ◽

Hirofumi Mukai ◽

Toshiaki Saeki ◽

Jungsil Ro ◽

Yung-Chang Lin ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Recurrent Breast Cancer ◽

Phase Iii ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

A global phase III clinical study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients

Annals of Oncology ◽

10.1093/annonc/mdx365.013 ◽

2017 ◽

Vol 28 ◽

pp. v80-v81 ◽

Author(s):

T. Saeki ◽

H. Mukai ◽

J. Ro ◽

Y-C. Lin ◽

Y. Fujiwara ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Cancer Patients ◽

Recurrent Breast Cancer ◽

Phase Iii ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

Hypofractionated (HF) Versus Conventional Fractionated (CF) Radiotherapy for Breast Cancer Patients Treated with Breast Conserving Surgery: A Randomized, Phase III, Open-Label, Non-Inferiority Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.1029 ◽

2020 ◽

Vol 108 (3) ◽

pp. e18

Author(s):

S.L. Wang ◽

Y.W. Song ◽

C. Hu ◽

W.H. Wang ◽

H. Fang ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Breast Conserving Surgery ◽

Phase Iii ◽

Breast Cancer Patients ◽

Download Full-text

Additional Safety Results of Hannah: A Phase III Randomised, Open-Label, International Study of the Subcutaneous Formulation of Trastuzumab (H) in HER2-Positive Early Breast Cancer Patients

Annals of Oncology ◽

10.1016/s0923-7534(20)32833-7 ◽

2012 ◽

Vol 23 ◽

pp. ix102-ix103

Author(s):

C. Jackisch ◽

M. Dank ◽

G. Frasci ◽

K.H. Park ◽

R.I. Lopez ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

International Study ◽

Phase Iii ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Additional Safety

Download Full-text

Abstract CT302: A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic or recurrent breast cancer patients with triple negative disease

10.1158/1538-7445.am2014-ct302 ◽

2014 ◽

Author(s):

Stacy Cowherd ◽

Susan Melin ◽

Steven Akman ◽

John Cole ◽

Julia Lawrence

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Cancer Patients ◽

Phase Ii ◽

Triple Negative ◽

Recurrent Breast Cancer ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

Abstract OT1-03-05: A phase III, randomized, open label, multicenter, controlled trial of niraparib versus physician's choice in previously- treated, HER2 negative, germline BRCA mutation-positive breast cancer patients. An EORTC-BIG intergroup study (BRAVO study)

10.1158/1538-7445.sabcs15-ot1-03-05 ◽

2016 ◽

Author(s):

J Balmana ◽

K Tryfonidis ◽

W Audeh ◽

T Goulioti ◽

L Slaets ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Controlled Trial ◽

Brca Mutation ◽

Phase Iii ◽

Breast Cancer Patients ◽

Germline Brca Mutation ◽

Previously Treated ◽

Positive Breast Cancer

Download Full-text

218. T-DM1 therapy for advanced or recurrent breast cancer patients in the late line

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2016.06.151 ◽

2016 ◽

Vol 42 (9) ◽

pp. S126

Author(s):

T. Morimoto ◽

S. Michishita

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Recurrent Breast Cancer ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

Efficacy of fulvestrant 500 mg in Japanese postmenopausal advanced/recurrent breast cancer patients and factors associated with prolonged time-to-treatment failure

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2015.1107042 ◽

2015 ◽

Vol 16 (17) ◽

pp. 2561-2568 ◽

Author(s):

Kazuhiro Araki ◽

Naoko Ishida ◽

Rie Horii ◽

Shunji Takahashi ◽

Futoshi Akiyama ◽

...

Keyword(s):

Breast Cancer ◽

Treatment Failure ◽

Cancer Patients ◽

Recurrent Breast Cancer ◽

Breast Cancer Patients ◽

Time To Treatment ◽

Factors Associated ◽

Prolonged Time ◽

Time To Treatment Failure ◽

Recurrent Breast

Download Full-text

Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients

Breast Cancer ◽

10.2325/jbcs.13.159 ◽

2006 ◽

Vol 13 (2) ◽

pp. 159-165 ◽

Author(s):

Toshiaki Saeki ◽

Shigemitsu Takashima ◽

Masami Ogita ◽

Toshio Tabei ◽

Isamu Adachi ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Cancer Patients ◽

Combination Chemotherapy ◽

Recurrent Breast Cancer ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

Serum prolactin responses to TRH in recurrent breast cancer patients.

Endocrinologia Japonica ◽

10.1507/endocrj1954.26.141 ◽

1979 ◽

Vol 26 (1) ◽

pp. 141-145 ◽

Author(s):

MICHIO MIYAZAKI ◽

KAZUHIKO YASUMURA ◽

SATOSHI II ◽

YASUAKI TAKATA ◽

TOSHIAKI KAMI

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Recurrent Breast Cancer ◽

Serum Prolactin ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

Clinical and dosimetric evaluation of recurrent breast cancer patients treated with hyperthermia and radiation

International Journal of Hyperthermia ◽

10.1080/02656736.2019.1660810 ◽

2019 ◽

Vol 36 (1) ◽

pp. 985-991 ◽

Author(s):

Sharvari Dharmaiah ◽

Johnathan Zeng ◽

Vinay S. Rao ◽

Zi Ouyang ◽

Tianjun Ma ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Recurrent Breast Cancer ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text